Founded in late 2007, Sync-Rx seeks and introduces major improvements in the efficiency, safety and simplicity of trans-catheter cardiovascular interventions by leveraging the company's proprietary and patent-pending technologies.

The company's immediate focus is on add-on products aimed at improving coronary angioplasty, a catheterization procedure whereby balloons and stents are employed to widen narrowed sections in the arteries providing the heart muscle with the necessary blood supply. Millions of coronary angioplasty procedures are preformed annually worldwide, creating a substantial opportunity for the company.

www.sync-rx.com